188 related articles for article (PubMed ID: 9189149)
1. Alterations of myocardial sympathetic innervation in response to hypoxia.
Scherrer-Crosbie M; Mardon K; Cayla J; Syrota A; Merlet P
J Nucl Med; 1997 Jun; 38(6):954-7. PubMed ID: 9189149
[TBL] [Abstract][Full Text] [Related]
2. MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia.
Richalet JP; Merlet P; Bourguignon M; Le-Trong JL; Kéromès A; Rathat C; Jouve B; Hot MA; Castaigne A; Syrota A
J Nucl Med; 1990 Jan; 31(1):34-7. PubMed ID: 2295937
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sympathetic nerve function assessed by [131I]metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs.
Takatsu H; Duncker CM; Arai M; Becker LC
J Nucl Cardiol; 1997; 4(1 Pt 1):35-41. PubMed ID: 9138838
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic imaging with 123I-metaiodobenzylguanidine as a marker of cardiac adrenergic neurotransmission in the rat.
Gayheart-Walsten P; Snyder D; Mack J; Boland C; Roberts J
Methods Find Exp Clin Pharmacol; 1995 May; 17(4):249-54. PubMed ID: 7475511
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
[TBL] [Abstract][Full Text] [Related]
7. Assessment of adrenergic neuron function altered with progression of heart failure.
Wakasugi S; Inoue M; Tazawa S
J Nucl Med; 1995 Nov; 36(11):2069-74. PubMed ID: 7472601
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
9. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Kiyono Y; Iida Y; Kawashima H; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med; 2001 Jul; 28(7):894-9. PubMed ID: 11504086
[TBL] [Abstract][Full Text] [Related]
10. Dual-tracer autoradiography with thallium-201 and iodine-125-metaiodobenzylguanidine in experimental myocardial infarction of rat.
Iwasaki T; Suzuki T; Tateno M; Sasaki Y; Oshima S; Imai S
J Nucl Med; 1996 Apr; 37(4):680-4. PubMed ID: 8691266
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure.
Kurata C; Wakabayashi Y; Shouda S; Okayama K; Yamamoto T; Ishikawa A; Suzuki K; Ishizuka T; Sakamoto S; Tawarahara K
J Nucl Med; 1995 Nov; 36(11):2037-43. PubMed ID: 7472594
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of metaiodobenzylguanidine imaging in cardiology.
Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746
[TBL] [Abstract][Full Text] [Related]
13. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
Dubois EA; Kam KL; Somsen GA; Boer GJ; de Bruin K; Batink HD; Pfaffendorf M; van Royen EA; van Zwieten PA
Eur J Nucl Med; 1996 Aug; 23(8):901-8. PubMed ID: 8753678
[TBL] [Abstract][Full Text] [Related]
14. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
15. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation.
De Marco T; Dae M; Yuen-Green MS; Kumar S; Sudhir K; Keith F; Amidon TM; Rifkin C; Klinski C; Lau D
J Am Coll Cardiol; 1995 Mar; 25(4):927-31. PubMed ID: 7884099
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content.
Dae MW; O'Connell JW; Botvinick EH; Chin MC
Cardiovasc Res; 1995 Aug; 30(2):270-80. PubMed ID: 7585815
[TBL] [Abstract][Full Text] [Related]
17. [Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy].
Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T
Kaku Igaku; 1990 Jul; 27(7):703-8. PubMed ID: 2232338
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M
Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490
[TBL] [Abstract][Full Text] [Related]
19. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.
Kurata C; Okayama K; Wakabayashi Y; Shouda S; Mikami T; Tawarahara K; Sugiyama T
J Nucl Med; 1997 Nov; 38(11):1677-80. PubMed ID: 9374332
[TBL] [Abstract][Full Text] [Related]
20. Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
Somsen GA; van Vlies B; de Milliano PA; Borm JJ; van Royen EA; Endert E; Lie KI
Heart; 1996 Sep; 76(3):218-22. PubMed ID: 8868979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
